• Skip to Main Content
VIATRIS Logo
  • IndicationREVATIO® (sildenafil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

    Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.
  • Important Safety Information
  • Prescribing Information
  • Patient Information
  • Healthcare Professionals
20 mg tablets logo
SAVINGS Terms and conditions apply.
Download icon Email icon
  • ABOUT
  • TAKING REVATIO
  • FAQs
  • RESOURCES

WHY REVATIO

For over 15 years, brand-name REVATIO has helped treat pulmonary arterial hypertension (PAH) in adults. If you have PAH, ask your doctor about moving forward with brand-name REVATIO.

Lung icon

REVATIO IS CLINICALLY PROVEN

In a clinical study of 267 PAH patients,† REVATIO taken with epoprostenol:

  • Increased the distance people walked in a 6-minute defined time

  • Decreased pressure in the pulmonary artery‡

  • Helped lessen symptoms of PAH§

  • Helped slow down worsening changes in physical condition||

†All patients continued intravenous epoprostenol therapy.

‡Patients on REVATIO achieved a statistically important reduction in mPAP vs placebo.

§Measured by improvements in WHO functional class (classifies patients based on limitations of physical activity and symptoms).

||REVATIO patients had a significant delay to clinical worsening and were less likely to experience clinical worsening (death, lung transplantation, initiation of bosentan, or clinical deterioration) vs placebo.

Shield icon

REVATIO IS THE BRAND YOU RECOGNIZE

  • The REVATIO pill has a distinctive shape and marking to let you know you're getting the brand-name medication—pill to pill, month to month

  • If your pill does not say RVT 20, and you want brand-name REVATIO, talk to your pharmacist

Pill image

REVATIO OFFERS SAVINGS TO PATIENTS

If eligible, patients may pay as little as $0 each month for brand-name REVATIO—and could save up to $12,000 a year.*

Image of Savings Card
Image of Savings Card
Get your card
Have a card? Activate 
*Terms & Conditions apply.

LEARN MORE ABOUT REVATIO

  • Taking REVATIO
  • How to Get Brand-Name REVATIO
  • Safety & Possible Side Effects

IMPORTANT SAFETY INFORMATION AND INDICATION

collapsecollapsecollapse

DO NOT take REVATIO® (sildenafil) with any nitrate medicines or with riociguat (Adempas®), a soluble guanylate cyclase (sGC) stimulator medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), or riociguat, a soluble guanylate cyclase (sGC) stimulator medicine, your blood pressure could drop quickly to an unsafe level.

Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO. REVATIO is not for use in children.

REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer), does not result in improvement in your ability to exercise.

If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats, and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

Tell your healthcare provider if you have any blood cell problems, including sickle cell anemia. Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure-lowering drugs or alpha-blockers for prostate.

Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

Erections that last for more than 4 hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than 6 hours may lead to long-term loss of potency.

Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

Tell your healthcare provider if you are breastfeeding. REVATIO passes into your breast milk; it is not known if it could harm your baby.

The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping, as well as fever, erection increased, respiratory infection, nausea, vomiting, bronchitis, pharyngitis, runny nose, and pneumonia in children.

INDICATION

REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

Adempas® is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

Tracleer® is a registered trademark of Actelion Pharmaceuticals Ltd.

Please see Full Prescribing Information and Patient Information.

YOU ARE NOW LEAVING REVATIO.COM, A VIATRIS INC., COMPANY WEBSITE

The website you are about to access is not owned or controlled by VIATRIS™. Links to other websites are provided as a convenience to users and the inclusion of any link does not imply the endorsement of the linked site by Viatris. Viatris accepts no responsibility for the content of any linked sites.

The information provided in REVATIO.COM/HCP is intended only for healthcare professionals in the United States.

CONTINUE
Stay on this site

s IMPORTANT SAFETY INFORMATION AND INDICATION

DO NOT take REVATIO® (sildenafil) with any nitrate medicines or with riociguat (Adempas®), a soluble guanylate cyclase (sGC) stimulator medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), or riociguat, a soluble guanylate cyclase (sGC) stimulator medicine, your blood pressure could drop quickly to an unsafe level.

Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO. REVATIO is not for use in children.

REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer), does not result in improvement in your ability to exercise.

If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats, and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

Tell your healthcare provider if you have any blood cell problems, including sickle cell anemia. Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure-lowering drugs or alpha-blockers for prostate.

Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

Erections that last for more than 4 hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than 6 hours may lead to long-term loss of potency.

Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

Tell your healthcare provider if you are breastfeeding. REVATIO passes into your breast milk; it is not known if it could harm your baby.

The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping, as well as fever, erection increased, respiratory infection, nausea, vomiting, bronchitis, pharyngitis, runny nose, and pneumonia in children.

INDICATION

REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

Adempas® is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

Tracleer® is a registered trademark of Actelion Pharmaceuticals Ltd.

Please see Full Prescribing Information and Patient Information.

Important Safety Information and Indication

DO NOT take REVATIO® (sildenafil) with any nitrate medicines or with riociguat (Adempas®), a soluble guanylate cyclase (sGC) stimulator medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), or riociguat, a soluble guanylate cyclase (sGC) stimulator medicine, your blood pressure could drop quickly to an unsafe level.

Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO. REVATIO is not for use in children.

REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer), does not result in improvement in your ability to exercise.

If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats, and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

Tell your healthcare provider if you have any blood cell problems, including sickle cell anemia. Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure-lowering drugs or alpha-blockers for prostate.

Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

Erections that last for more than 4 hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than 6 hours may lead to long-term loss of potency.

Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

Tell your healthcare provider if you are breastfeeding. REVATIO passes into your breast milk; it is not known if it could harm your baby.

The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping, as well as fever, erection increased, respiratory infection, nausea, vomiting, bronchitis, pharyngitis, runny nose, and pneumonia in children.

INDICATION

REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

Adempas® is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

Tracleer® is a registered trademark of Actelion Pharmaceuticals Ltd.

Please see Full Prescribing Information and Patient Information.

REVATIO SAVINGS CARD TERMS AND CONDITIONS

By participating in the REVATIO Savings Offer Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

  • Patients are not eligible to use this Savings Offer if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs healthcare, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”)
  • Patients must have private insurance. This Savings Offer is not valid for cash-paying patients. The value of this Savings Offer is limited to $1,000 per use or the amount of your co-pay, whichever is less
  • This Savings Offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other health or pharmacy benefit programs
  • You must deduct the savings received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf
  • You are responsible for reporting use of this Savings Offer to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using this Savings Offer, as may be required. You should not use this Savings Offer if your insurer or health plan prohibits use of manufacturer Savings Offers
  • Eligible patients may pay a minimum of $0 per monthly prescription fill. By using this Savings Offer, eligible patients may receive a savings of up to $1,000 per fill off their co-pay or out-of-pocket costs. This Savings Offer is available for a maximum savings of $12,000 per year ($1,000 per month x 12 months). This Savings Offer may limit your prescription cost to $0, subject to a $1,000 maximum monthly benefit. Thus, if your co-pay or out-of-pocket cost is more than $1,000, you will save $1,000 off of your co-pay or total out-of-pocket costs. [Example: If your co-pay or out-of-pocket costs are $1,025, you will pay $25 ($1,025 – $1,000 = $25).] If your co-pay or out-of-pocket costs are no more than $1,000, you pay $0. For a mail-order 3-month prescription, your total maximum savings may be $3,000 ($1,000 x 3)
  • You must be 18 years of age or older to redeem this Savings Offer
  • This Savings Offer is not valid (i) for Massachusetts residents or (ii) for California residents whose prescriptions are covered, in whole or in part, by third-party insurance
  • This Savings Offer is not valid where prohibited by law
  • This Savings Offer is not valid for purchases of prescriptions discounted under the 340B drug pricing program
  • This Savings Offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
  • This Savings Offer will be accepted only at participating pharmacies
  • This Savings Offer is not health insurance
  • This Savings Offer may not be redeemed more than once per 30 days per patient
  • This Savings Offer is good only in the U.S. and Puerto Rico
  • This Savings Offer is limited to 1 per person during this offering period and is not transferable
  • No other purchase is necessary
  • Data related to your redemption of this Savings Offer may be collected, analyzed, and shared with VIATRIS™ for market research and other purposes related to assessing Viatris’s programs. Data shared with Viatris will be aggregated and de-identified; it will be combined with data related to other Savings Offer redemptions and will not identify you
  • Viatris reserves the right to rescind, revoke, or amend the program without notice
  • No membership fees. This Savings Offer and Program expire on 12/31/2023
  • For further information, call 1-866-732-4468, visit REVATIO.com, or write: Viatris Inc., P.O. Box 2941, Mission, KS 66201

If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this Savings Offer. Pay for your REVATIO prescription and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: REVATIO Savings Offer, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Be sure to include a copy of the front of your REVATIO Savings Card, your name, and mailing address. Please expect up to 4 to 6 weeks for reimbursement.

REVATIO is available by prescription as a 20 mg tablet and 10 mg/mL oral suspension.

Patients should always ask their doctors for medical advice about adverse events.

You are encouraged to report adverse events related to Viatris products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit http://www.fda.gov/MedWatch or call 1-800-FDA-1088.

This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

Important Safety Information and Indication
+-

DO NOT take REVATIO® (sildenafil) with any nitrate medicines or with riociguat (Adempas®), a soluble guanylate cyclase (sGC) stimulator medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), or riociguat, a soluble guanylate cyclase (sGC) stimulator medicine, your blood pressure could drop quickly to an unsafe level.

Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO. REVATIO is not for use in children.

REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer), does not result in improvement in your ability to exercise.

If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats, and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

Tell your healthcare provider if you have any blood cell problems, including sickle cell anemia. Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure-lowering drugs or alpha-blockers for prostate.

Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

Erections that last for more than 4 hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than 6 hours may lead to long-term loss of potency.

Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

Tell your healthcare provider if you are breastfeeding. REVATIO passes into your breast milk; it is not known if it could harm your baby.

The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping, as well as fever, erection increased, respiratory infection, nausea, vomiting, bronchitis, pharyngitis, runny nose, and pneumonia in children.

INDICATION

REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

Adempas® is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

Tracleer® is a registered trademark of Actelion Pharmaceuticals Ltd.

Please see Full Prescribing Information and Patient Information.

DO NOT take REVATIO® (sildenafil) with any nitrate medicines or with riociguat (Adempas®), a soluble guanylate cyclase (sGC) stimulator medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), or riociguat, a soluble guanylate cyclase (sGC) stimulator medicine, your blood pressure could drop quickly to an unsafe level.

Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO. REVATIO is not for use in children.

REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer), does not result in improvement in your ability to exercise.

If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats, and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

Tell your healthcare provider if you have any blood cell problems, including sickle cell anemia. Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure-lowering drugs or alpha-blockers for prostate.

Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

Erections that last for more than 4 hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than 6 hours may lead to long-term loss of potency.

Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

Tell your healthcare provider if you are breastfeeding. REVATIO passes into your breast milk; it is not known if it could harm your baby.

The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping, as well as fever, erection increased, respiratory infection, nausea, vomiting, bronchitis, pharyngitis, runny nose, and pneumonia in children.

INDICATION

REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

Limitation of Use: Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

Adempas® is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

Tracleer® is a registered trademark of Actelion Pharmaceuticals Ltd.

Please see Full Prescribing Information and Patient Information.

VIATRIS Logo
  • Terms of Use
  • Privacy Policy
  • California Supplemental Disclosure
  • Site Map
  • Contact Viatris
  • About Viatris

© 2022 Viatris Inc. All rights reserved.

REVATIO is a registered trademark of Viatris Specialty LLC, a Viatris Company. VIATRIS and the Viatris logo are trademarks of Mylan Inc., a Viatris Company.

PP-REV-USA-0202